Original Biomedicals Co Ltd Statistics
Original Biomedicals Co Ltd (6483) Stock Statistics & Valuation Metrics
Total Valuation
Original Biomedicals Co Ltd has a market cap or net worth of TWD 1.02B. The enterprise value is ―.
- Market Cap
- TWD 1.02B
- Enterprise Value
- ―
Share Statistics
Original Biomedicals Co Ltd has 66,808,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 66,808,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Original Biomedicals Co Ltd’s return on equity (ROE) is -0.64 and return on invested capital (ROIC) is -61.08%.
- Return on Equity (ROE)
- -0.64
- Return on Assets (ROA)
- -0.55
- Return on Invested Capital (ROIC)
- -61.08%
- Return on Capital Employed (ROCE)
- -0.63
- Revenue Per Employee
- 15.24K
- Profits Per Employee
- -4.06M
- Employee Count
- 25
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Original Biomedicals Co Ltd is -9.19. Original Biomedicals Co Ltd’s PEG ratio is 0.62.
- PE Ratio
- -9.19
- PS Ratio
- 0.00
- PB Ratio
- 8.50
- Price to FCF
- -7.53
- Price to Operating Cash Flow
- -7.70
- PEG Ratio
- 0.62
Income Statement
In the last 12 months, Original Biomedicals Co Ltd had revenue of 381.00K and earned -101.51M in profits. Earnings per share was -1.54.
- Revenue
- 381.00K
- Gross Profit
- 306.00K
- Operating Income
- -104.60M
- Pretax Income
- -101.51M
- Net Income
- -101.51M
- EBITDA
- -92.09M
- Earnings Per Share (EPS)
- -1.54
Cash Flow
In the last 12 months, operating cash flow was -122.49M and capital expenditures -3.11M, giving a free cash flow of -125.60M billion.
- Operating Cash Flow
- -122.49M
- Free Cash Flow
- -125.60M
- Free Cash Flow per Share
- -1.88
Dividends & Yields
Original Biomedicals Co Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -12.75%
- Earnings Yield
- -10.40%
Stock Price Statistics
- Beta
- 0.36
- 52-Week Price Change
- 48.06%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 64.04
- Average Volume (3m)
- 195.27K
Financial Position
Original Biomedicals Co Ltd as a current ratio of 9.74, with Debt / Equity ratio of 7.09%
- Current Ratio
- 9.74
- Quick Ratio
- 9.74
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 1.33
- Interest Coverage Ratio
- -177.28
Taxes
In the past 12 months, Original Biomedicals Co Ltd has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Original Biomedicals Co Ltd EV to EBITDA ratio is -10.22, with an EV/FCF ratio of -7.43.
- EV to Sales
- 0.00
- EV to EBITDA
- -10.22
- EV to Free Cash Flow
- -7.43
- EV to Operating Cash Flow
- -7.62
Balance Sheet
Original Biomedicals Co Ltd has TWD 70.77M in cash and marketable securities with TWD 9.16M in debt, giving a net cash position of TWD 61.61M billion.
- Cash & Marketable Securities
- TWD 70.77M
- Total Debt
- TWD 9.16M
- Net Cash
- TWD 61.61M
- Net Cash Per Share
- TWD 0.92
- Tangible Book Value Per Share
- TWD 1.66
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Original Biomedicals Co Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -100.00%
- EPS Growth Forecast
- -15.02%
